HOME >> BIOLOGY >> NEWS
Could hibernators hold the key to improving organ preservation?

April 9, 2003 (San Diego, CA) -- Each day about 63 people receive an organ transplant, but another 16 people on the waiting list die because not enough organs are available. "Available" is the operative word in this shortage of transplantable organs.

A donor's gift may be available, but the transportation time to the sick patient, coupled with the period that an organ can be safely preserved without damage, may indicate that those on the waiting list are victims of logistics as well as availability.

Currently, organs such as the liver or pancreas can be stored for 36 hours, though damage occurs after a day. Hibernating mammals may provide new insights to extend storage times and improve the quality of cold-stored organs. Each winter, hibernators such as ground squirrels and marmots undergo periods of torpor in which body temperature and metabolic rate are only a fraction of normal levels, without damage to their organs. For weeks at a time, hibernators maintain a body temperature close to zero degrees Celsius, which is similar to that used for human organ preservation.

Researchers at the University of Wisconsin and the University of Colorado set out to study hibernating mammals as a model for organ tolerance to extended cold preservation. The researchers are Dr. Hannah Carey at the University of Wisconsin-Madison School of Veterinary Medicine, Dr. James Southard at the UW-Madison Medical School and Dr. Sandy Martin at the University of Colorado Health Sciences Center in Denver. Their findings are being presented at Experimental Biology 2003, a conference sponsored by the American Physiological Society, being held April 11-15, 2003 at the San Diego Convention Center, San Diego, CA.

Background

Previous studies from this research team suggest that livers from hibernating ground squirrels show superior tolerance to extended cold storage when compared to a non-hibernator, such as the rat. The tolerance in sum
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-967-2751
American Physiological Society
9-Apr-2003


Page: 1 2 3

Related biology news :

1. Endometriosis: Could angiostatic therapy be the new treatment of the future?
2. Could mice hold the secret to longer life?
3. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
4. Could memory performance and spatial learning be genetically based?
5. Could a specific protein contribute to erectile dysfunction for the diabetic and obese?
6. Could diabetes treatments fight cancer?
7. Could rice be the source for a natural herbicide?
8. Could Bt transgenic crops have nutritionally favourable effects on insects?
9. Could one less cookie a day help the fight against fat?
10. Could an anti-marijuana compound hold the key to body weight and appetite control?
11. Study finds genetic aberrations linked to lung cancer; Could help in early diagnosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Could hibernators hold the key improving organ preservation

(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: